CSBR Earnings & Financial Statements
Champions Oncology, Inc.
$4.81
$0.00(0.00%)
38
Overall
40
Value
30
Tech
44
Quality
Market Cap
$66.95M
Volume
85
52W Range
$4.59 - $8.31
Target Price
$12.00
CSBR earnings and financial statements: Champions Oncology, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CSBR Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $59.42M | $56.94M | $50.16M | $53.87M | $49.11M |
| Cost of revenue | -$30.90M | -$28.39M | $29.40M | $29.53M | $23.63M |
| Operating income | -$1.14M | $4.55M | -$7.36M | -$5.26M | $607.0K |
| EBITDA | -$69.0K | $6.42M | -$5.44M | -$3.00M | $2.23M |
| Net income | -$1.20M | $4.70M | -$7.28M | -$5.33M | $548.0K |
| EPS (diluted) | $-0.08 | $0.33 | $-0.54 | $-0.39 | $0.04 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $26.99M | $32.34M | $26.13M | $34.29M | $35.38M |
| Total liabilities | $22.92M | $28.57M | $28.04M | $29.68M | $26.28M |
| Shareholders’ equity | $3.94M | $3.77M | -$1.90M | $4.64M | $9.10M |
| Cash and equivalents | $4.90M | $9.80M | $2.60M | $10.10M | $9.00M |
| Long-term debt | $2.99M | $4.63M | $6.09M | $7.39M | $8.41M |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.47M | $7.39M | -$6.14M | $3.97M | $6.50M |
| Capital expenditure | -$540.0K | -$389.0K | -$836.0K | -$2.87M | -$2.38M |
| Free cash flow | -$5.04M | $7.00M | -$6.97M | $1.10M | $4.11M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CSBR | $4.81 | 0% | 85 |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Champions Oncology, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW